The HIV+Hepatitis Policy Institute, a non-profit organization, is very grateful for support from individuals, foundations, and corporations that invest in our mission to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. The HIV and Hepatitis Policy Institute is a 501(c)(3) tax-exempt organization. Donations to HIV+Hep are tax-deductible to the full extent allowed by law.
If you are interested in making a donation, please contact: Carl Schmid, Executive Director, at cschmid@hivhep.org.
1602B Belmont Street NW | Washington DC 20009
Facebook posts by @HIV+Hep
The HIV and Hepatitis Policy Institute's Carl Schmid presented data on prior authorization & prescription drugs before the National Association of Insurance Commissioners. 31% of first fills of brand name #Rx’s were rejected due to utilization management in exchange plans: bit.ly/4hwYbIT
Community groups lose HIV-prevention money as feds redirect dollars to states:
Community groups lose HIV-prevention money as feds redirect dollars to states • Stateline
stateline.org
Nearly 100 community-based organizations have lost their federal HIV-prevention grants this week as the Trump administration redirects dollars to state and local health departments. The funding change...
CDC HIV Funding Shift Raises Concerns for Community-Based Organizations:
CDC HIV Funding Shift Raises Concerns for Community-Based Organizations
www.cfpublic.org
The funding for HIV prevention is shifting to state and local health departments instead of going directly to community-based organizations.
.Blue Cross and Blue Shield Association is charging federal employees excessively high copays for twice-yearly #prep—as much as 50-60 % co-insurance, violating federal preventive coverage requirements. We are urging the Office of Personnel Management (OPM) to put an end to this: bit.ly/4iSr03L
Three Years Since Court Victory & Prescription Drug Copay Assistance Still Not Counting for Patients. Administration Must Enforce Court Victory to Lower Drug Costs for Patients & End Insurers’ Double-Charging: bit.ly/4AkNvV3